Increased	VBN	B-NP	O	Other	###	1	Increased	Increased	VBN	VBN	_	3	amod	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	2	IL-17	IL-17	NN	NN	_	3	compound	_	_
production	NN	I-NP	O	Other	###	3	production	production	NN	NN	_	0	root	_	_
in	IN	B-PP	O	Other	###	4	in	in	IN	IN	_	5	case	_	_
PBMC	NN	B-NP	B-cell_type	Other	###	5	PBMC	PBMC	NN	NN	_	3	nmod	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	7	case	_	_
patients	NNS	B-NP	O	Other	###	7	patients	patients	NNS	NNS	_	5	nmod	_	_
with	IN	B-PP	O	Other	###	8	with	with	IN	IN	_	9	case	_	_
RA	NN	B-NP	O	Other	###	9	RA	RA	NN	NN	_	7	nmod	_	_
by	IN	B-PP	O	Other	###	10	by	by	IN	IN	_	11	case	_	_
anti-CD3	JJ	B-ADJP	B-protein	Other	###	11	anti-CD3	anti-CD3	JJ	JJ	_	3	nmod	_	_
and	CC	I-ADJP	O	Other	###	12	and	and	CC	CC	_	11	cc	_	_
/	/	O	O	Other	###	13	/	/	/	/	_	11	punct	_	_
or	CC	I-ADJP	O	Other	###	14	or	or	CC	CC	_	11	cc	_	_
anti	NN	B-NP	O	Other	###	15	anti	anti	NN	NN	_	11	conj	_	_
-	-	O	O	Other	###	16	-	-	-	-	_	15	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	17	CD28	CD28	NN	NN	_	15	conj	_	_
,	,	O	O	Other	###	18	,	,	,	,	_	11	punct	_	_
and	CC	O	O	Other	###	19	and	and	CC	CC	_	11	cc	_	_
PHA	NN	B-NP	B-protein	B-Protein	###	20	PHA	PHA	NN	NN	_	11	conj	_	_

Because	IN	B-SBAR	O	Other	###	1	Because	Because	IN	IN	_	5	mark	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	2	IL-17	IL-17	NN	NN	_	5	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	3	was	was	VBD	VBD	_	5	auxpass	_	_
already	RB	I-VP	O	Other	###	4	already	already	RB	RB	_	5	advmod	_	_
known	VBN	I-VP	O	Other	###	5	known	known	VBN	VBN	_	19	advcl	_	_
from	IN	B-PP	O	Other	###	6	from	from	IN	IN	_	8	case	_	_
earlier	JJR	B-NP	O	Other	###	7	earlier	earlier	JJR	JJR	_	8	amod	_	_
reports	NNS	I-NP	O	Other	###	8	reports	reports	NNS	NNS	_	5	nmod	_	_
to	TO	B-VP	O	Other	###	9	to	to	TO	TO	_	11	mark	_	_
be	VB	I-VP	O	Other	###	10	be	be	VB	VB	_	11	auxpass	_	_
produced	VBN	I-VP	O	Other	###	11	produced	produced	VBN	VBN	_	5	xcomp	_	_
mainly	RB	B-ADVP	O	Other	###	12	mainly	mainly	RB	RB	_	16	advmod	_	_
by	IN	B-PP	O	Other	###	13	by	by	IN	IN	_	16	case	_	_
activated	VBN	B-NP	B-cell_type	Other	###	14	activated	activated	VBN	VBN	_	16	amod	_	_
T	NN	I-NP	I-cell_type	Other	###	15	T	T	NN	NN	_	16	compound	_	_
cells	NNS	I-NP	I-cell_type	Other	###	16	cells	cells	NNS	NNS	_	11	nmod	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	19	punct	_	_
we	PRP	B-NP	O	Other	###	18	we	we	PRP	PRP	_	19	nsubj	_	_
investigated	VBD	B-VP	O	Other	###	19	investigated	investigated	VBD	VBD	_	0	root	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	21	det	_	_
effect	NN	I-NP	O	Other	###	21	effect	effect	NN	NN	_	19	dobj	_	_
of	IN	B-PP	O	Other	###	22	of	of	IN	IN	_	24	case	_	_
different	JJ	B-NP	O	Other	###	23	different	different	JJ	JJ	_	24	amod	_	_
concentrations	NNS	I-NP	O	Other	###	24	concentrations	concentrations	NNS	NNS	_	21	nmod	_	_
of	IN	B-PP	O	Other	###	25	of	of	IN	IN	_	26	case	_	_
anti-CD3	NN	B-NP	B-protein	Other	###	26	anti-CD3	anti-CD3	NN	NN	_	24	nmod	_	_
(	(	O	O	Other	###	27	(	(	(	(	_	33	punct	_	_
1	CD	B-NP	O	Other	###	28	1	1	CD	CD	_	33	nummod	_	_
,	,	I-NP	O	Other	###	29	,	,	,	,	_	28	punct	_	_
5	CD	I-NP	O	Other	###	30	5	5	CD	CD	_	33	nummod	_	_
and	CC	I-NP	O	Other	###	31	and	and	CC	CC	_	30	cc	_	_
10	CD	I-NP	O	Other	###	32	10	10	CD	CD	_	30	conj	_	_
mug	NN	I-NP	O	Other	###	33	mug	mug	NN	NN	_	26	dep	_	_
/	/	O	O	Other	###	34	/	/	/	/	_	35	punct	_	_
ml	NN	I-NP	O	Other	###	35	ml	ml	NN	NN	_	33	appos	_	_
)	)	O	O	Other	###	36	)	)	)	)	_	35	punct	_	_
as	IN	B-PP	O	Other	###	37	as	as	IN	IN	_	41	case	_	_
a	DT	B-NP	O	Other	###	38	a	a	DT	DT	_	41	det	_	_
T	NN	I-NP	O	Other	###	39	T	T	NN	NN	_	41	compound	_	_
cell	NN	I-NP	O	Other	###	40	cell	cell	NN	NN	_	41	compound	_	_
activation	NN	I-NP	O	Other	###	41	activation	activation	NN	NN	_	21	nmod	_	_
,	,	O	O	Other	###	42	,	,	,	,	_	21	punct	_	_
which	WDT	B-NP	O	Other	###	43	which	which	WDT	WDT	_	44	nsubj	_	_
showed	VBD	B-VP	O	Other	###	44	showed	showed	VBD	VBD	_	21	acl:relcl	_	_
a	DT	B-NP	O	Other	###	45	a	a	DT	DT	_	49	det	_	_
dose	JJ	I-NP	O	Other	###	46	dose	dose	JJ	JJ	_	49	amod	_	_
-	-	O	O	Other	###	47	-	-	-	-	_	46	punct	_	_
dependent	JJ	I-NP	O	Other	###	48	dependent	dependent	JJ	JJ	_	46	dep	_	_
increase	NN	I-NP	O	Other	###	49	increase	increase	NN	NN	_	44	dobj	_	_
in	IN	B-PP	O	Other	###	50	in	in	IN	IN	_	52	case	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	51	IL-17	IL-17	NN	NN	_	52	compound	_	_
levels	NNS	I-NP	O	Other	###	52	levels	levels	NNS	NNS	_	49	nmod	_	_
(	(	O	O	Other	###	53	(	(	(	(	_	54	punct	_	_
data	NNS	B-NP	O	Other	###	54	data	data	NNS	NNS	_	49	dep	_	_
not	RB	B-VP	O	Other	###	55	not	not	RB	RB	_	56	neg	_	_
shown	VBN	I-VP	O	Other	###	56	shown	shown	VBN	VBN	_	54	acl	_	_
)	)	O	O	Other	###	57	)	)	)	)	_	54	punct	_	_
.	.	O	O	Other	###	58	.	.	.	.	_	19	punct	_	_

On	IN	B-PP	O	Other	###	1	On	On	IN	IN	_	3	case	_	_
the	DT	B-NP	O	Other	###	2	the	the	DT	DT	_	3	det	_	_
basis	NN	I-NP	O	Other	###	3	basis	basis	NN	NN	_	8	nmod	_	_
of	IN	B-PP	O	Other	###	4	of	of	IN	IN	_	5	case	_	_
this	DT	B-NP	O	Other	###	5	this	this	DT	DT	_	3	nmod	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	8	punct	_	_
we	PRP	B-NP	O	Other	###	7	we	we	PRP	PRP	_	8	nsubj	_	_
chose	VBD	B-VP	O	Other	###	8	chose	chose	VBD	VBD	_	0	root	_	_
10	CD	B-NP	O	Other	###	9	10	10	CD	CD	_	10	nummod	_	_
mug	NN	I-NP	O	Other	###	10	mug	mug	NN	NN	_	12	compound	_	_
/	/	O	O	Other	###	11	/	/	/	/	_	12	punct	_	_
ml	NN	I-NP	O	Other	###	12	ml	ml	NN	NN	_	8	dobj	_	_
as	IN	B-PP	O	Other	###	13	as	as	IN	IN	_	16	case	_	_
a	DT	B-NP	O	Other	###	14	a	a	DT	DT	_	16	det	_	_
stimulation	NN	I-NP	O	Other	###	15	stimulation	stimulation	NN	NN	_	16	compound	_	_
concentration	NN	I-NP	O	Other	###	16	concentration	concentration	NN	NN	_	8	nmod	_	_
for	IN	B-PP	O	Other	###	17	for	for	IN	IN	_	18	case	_	_
anti-CD3	NN	B-NP	B-protein	Other	###	18	anti-CD3	anti-CD3	NN	NN	_	16	nmod	_	_
.	.	O	O	Other	###	19	.	.	.	.	_	8	punct	_	_

As	IN	B-SBAR	O	Other	###	1	As	As	IN	IN	_	2	mark	_	_
shown	VBN	B-VP	O	Other	###	2	shown	shown	VBN	VBN	_	9	advcl	_	_
in	IN	B-PP	O	Other	###	3	in	in	IN	IN	_	4	case	_	_
Table	JJ	B-NP	O	Other	###	4	Table	Table	JJ	JJ	_	2	nmod	_	_
1	CD	I-NP	O	Other	###	5	1	1	CD	CD	_	4	nummod	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	9	punct	_	_
anti-CD3	JJ	B-NP	B-protein	Other	###	7	anti-CD3	anti-CD3	JJ	JJ	_	9	nsubj	_	_
significantly	RB	I-NP	O	Other	###	8	significantly	significantly	RB	RB	_	9	advmod	_	_
upregulated	VBN	I-NP	O	Other	###	9	upregulated	upregulated	VBN	VBN	_	0	root	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	10	IL-17	IL-17	NN	NN	_	11	compound	_	_
production	NN	I-NP	O	Other	###	11	production	production	NN	NN	_	9	dobj	_	_
up	IN	B-PP	O	Other	###	12	up	up	IN	IN	_	14	advmod	_	_
to	TO	B-PP	O	Other	###	13	to	to	TO	TO	_	12	mwe	_	_
3.7-fold	RB	B-ADVP	O	Other	###	14	3.7-fold	3.7-fold	RB	RB	_	9	nmod	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	9	punct	_	_
and	CC	O	O	Other	###	16	and	and	CC	CC	_	9	cc	_	_
the	DT	B-NP	O	Other	###	17	the	the	DT	DT	_	18	det	_	_
combination	NN	I-NP	O	Other	###	18	combination	combination	NN	NN	_	25	nsubj	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
anti	NN	B-NP	O	Other	###	20	anti	anti	NN	NN	_	18	nmod	_	_
-	-	O	O	Other	###	21	-	-	-	-	_	20	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	22	CD28	CD28	NN	NN	_	20	dep	_	_
and	CC	I-NP	O	Other	###	23	and	and	CC	CC	_	22	cc	_	_
anti-CD3	NN	I-NP	B-protein	Other	###	24	anti-CD3	anti-CD3	NN	NN	_	22	conj	_	_
produced	VBD	B-VP	O	Other	###	25	produced	produced	VBD	VBD	_	9	conj	_	_
more	JJR	B-NP	O	Other	###	26	more	more	JJR	JJR	_	27	amod	_	_
IL-17	NN	I-NP	B-protein	B-Protein	###	27	IL-17	IL-17	NN	NN	_	25	dobj	_	_
(	(	O	O	Other	###	28	(	(	(	(	_	30	punct	_	_
approximately	RB	B-ADVP	O	Other	###	29	approximately	approximately	RB	RB	_	30	advmod	_	_
1.3-1.5-fold	RB	I-ADVP	O	Other	###	30	1.3-1.5-fold	1.3-1.5-fold	RB	RB	_	27	dep	_	_
)	)	O	O	Other	###	31	)	)	)	)	_	30	punct	_	_
than	IN	B-PP	O	Other	###	32	than	than	IN	IN	_	33	case	_	_
anti-CD3	NN	B-NP	B-protein	Other	###	33	anti-CD3	anti-CD3	NN	NN	_	25	nmod	_	_
alone	RB	B-ADVP	O	Other	###	34	alone	alone	RB	RB	_	33	advmod	_	_
.	.	O	O	Other	###	35	.	.	.	.	_	9	punct	_	_

Furthermore	RB	B-ADVP	O	Other	###	1	Furthermore	Furthermore	RB	RB	_	18	advmod	_	_
,	,	O	O	Other	###	2	,	,	,	,	_	18	punct	_	_
when	WRB	B-ADVP	O	Other	###	3	when	when	WRB	WRB	_	4	advmod	_	_
incubated	VBN	B-VP	O	Other	###	4	incubated	incubated	VBN	VBN	_	18	advcl	_	_
with	IN	B-PP	O	Other	###	5	with	with	IN	IN	_	8	case	_	_
T	NN	B-NP	B-protein	Other	###	6	T	T	NN	NN	_	8	compound	_	_
cell	NN	I-NP	I-protein	Other	###	7	cell	cell	NN	NN	_	8	compound	_	_
mitogens	NNS	I-NP	I-protein	Other	###	8	mitogens	mitogens	NNS	NNS	_	4	nmod	_	_
such	JJ	B-PP	O	Other	###	9	such	such	JJ	JJ	_	11	case	_	_
as	IN	I-PP	O	Other	###	10	as	as	IN	IN	_	9	mwe	_	_
PHA	NN	B-NP	B-protein	B-Protein	###	11	PHA	PHA	NN	NN	_	8	nmod	_	_
,	,	O	O	Other	###	12	,	,	,	,	_	18	punct	_	_
increased	VBD	B-VP	O	Other	###	13	increased	increased	VBD	VBD	_	18	csubj	_	_
IL-17	NN	B-NP	B-protein	B-Protein	###	14	IL-17	IL-17	NN	NN	_	15	compound	_	_
production	NN	I-NP	O	Other	###	15	production	production	NN	NN	_	18	nsubj	_	_
was	VBD	B-VP	O	Other	###	16	was	was	VBD	VBD	_	18	aux	_	_
more	RBR	B-ADJP	O	Other	###	17	more	more	RBR	RBR	_	18	advmod	_	_
pronounced	JJ	I-ADJP	O	Other	###	18	pronounced	pronounced	JJ	JJ	_	0	root	_	_
than	IN	B-PP	O	Other	###	19	than	than	IN	IN	_	21	case	_	_
with	IN	B-PP	O	Other	###	20	with	with	IN	IN	_	21	case	_	_
anti-CD3	JJ	B-NP	B-protein	Other	###	21	anti-CD3	anti-CD3	JJ	JJ	_	18	nmod	_	_
and	CC	I-NP	O	Other	###	22	and	and	CC	CC	_	21	cc	_	_
anti	NN	B-NP	O	Other	###	23	anti	anti	NN	NN	_	21	conj	_	_
-	-	O	O	Other	###	24	-	-	-	-	_	21	punct	_	_
CD28	NN	B-NP	B-protein	B-Protein	###	25	CD28	CD28	NN	NN	_	21	conj	_	_
(	(	O	O	Other	###	26	(	(	(	(	_	21	punct	_	_
588	CD	B-NP	O	Other	###	27	588	588	CD	CD	_	21	dep	_	_
+/-	SYM	I-NP	O	Other	###	28	+/-	+/-	SYM	SYM	_	27	cc	_	_
85	CD	I-NP	O	Other	###	29	85	85	CD	CD	_	27	conj	_	_
versus	IN	B-PP	O	Other	###	30	versus	versus	IN	IN	_	29	cc	_	_
211	CD	B-NP	O	Other	###	31	211	211	CD	CD	_	29	conj	_	_
+/-	SYM	I-NP	O	Other	###	32	+/-	+/-	SYM	SYM	_	31	cc	_	_
1	CD	I-NP	O	Other	###	33	1	1	CD	CD	_	31	conj	_	_
pg	NN	I-NP	O	Other	###	34	pg	pg	NN	NN	_	36	compound	_	_
/	/	O	O	Other	###	35	/	/	/	/	_	36	punct	_	_
ml	NN	I-NP	O	Other	###	36	ml	ml	NN	NN	_	27	dep	_	_
;	:	O	O	Other	###	37	;	;	:	:	_	36	punct	_	_
P	NN	B-NP	O	Other	###	38	P	P	NN	NN	_	39	dep	_	_
<	SYM	B-NP	O	Other	###	39	<	<	SYM	SYM	_	36	dep	_	_
0.05	CD	I-NP	O	Other	###	40	0.05	0.05	CD	CD	_	39	nummod	_	_
)	)	O	O	Other	###	41	)	)	)	)	_	36	punct	_	_
.	.	O	O	Other	###	42	.	.	.	.	_	18	punct	_	_

